Nairobi, Kenya – A delegation from the Personal Care Products Council (PCPC) and Cosmetics Europe (CE) visited Kenya’s Pharmacy and Poisons Board (PPB) on November 13, 2024. Representing the cosmetics and personal care industries in the U.S. and Europe, the visit aimed to discuss potential collaboration with Kenyan authorities to strengthen the regulatory framework […]
Nakuru, Kenya – In a significant effort to protect public health, the Pharmacy and Poisons Board (PPB), in collaboration with the National Police Service, has launched a nationwide crackdown targeting the illegal distribution, wholesale, and transportation of pharmaceuticalson 12th November 2024. This intensified surveillance and enforcement initiative aims to eliminate malpractice in the pharmaceutical sector […]
Nakuru, Kenya – The Pharmacy and Poisons Board (PPB) has launched rigorous, ongoing audits of pharmaceutical wholesalers and Level 4 hospitals across Kenya, beginning October 13 for wholesalers and October 20 for hospitals. This initiative aims to enforce strict compliance with pharmaceutical regulations and enhance patient safety nationwide. Mr. Julius Kaluai, Head of Good Distribution […]
Nairobi , Kenya – October 24, 2024 – Kenya has officially launched the Kenya Surveillance System for Antimicrobial Consumption (KESAC), a national initiative aimed at monitoring antimicrobial use to combat antimicrobial resistance (AMR). Led by the Pharmacy and Poisons Board, KESAC will track antimicrobial consumption across the entire pharmaceutical supply chain. During the virtual […]
Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) completed a 10-day intensive coached audit for its Good Manufacturing Practices (GMP) Inspectors, aimed at enhancing their practical auditing skills. Supported by WHO-appointed GMP consultants, the training included local manufacturing site visits to address gaps identified in the previous WHO Global Benchmarking Tool audit. Participants gained […]
PPB Unveils 2024 Pharmacovigilance Systems Assessment Findings, Highlighting Progress and Challenges
Nairobi, October 9, 2024 – The Pharmacy and Poisons Board (PPB) presented the findings of the 2024 Pharmacovigilance Systems Assessment on Wednesday, October 9, 2024. This assessment, conducted in collaboration with IGAD, EAC, and supported by MTaPS, covered health facilities, Marketing Authorization Holders, and Public Health Programs. It showed notable progress in monitoring the safety […]
Nairobi, October 9, 2024 – Dr. F.M. Siyoi, the CEO of the Pharmacy and Poisons Board (PPB), chaired the inaugural Partners Forum aimed at enhancing collaboration among partners and stakeholders. During the forum, Dr. Siyoi emphasized the importance of promoting a unified strategic and coordinated approach to regulatory systems to improve access to safe Health […]
Nairobi, October 8, 2024 – Dr. Anthony Toroitich, Director of Corporate Services at the Pharmacy and Poisons Board (PPB), chaired a meeting with representatives from Tonix Pharmaceuticals, USA, during their familiarization visit. The discussions centered on clinical research and market authorization for vaccines. Dr. Toroitich highlighted PPB’s role in ensuring that all clinical trials in […]
Nairobi, 8th October 2024 – The Pharmacy and Poisons Board (PPB) Clinical Trials Division on October 8th, hosted a meeting with representatives from Genetic Immunity, Hungary. Dr. Anthony Toroitich, representing PPB CEO Dr. F. M. Siyoi, highlighted Kenya’s regulatory framework for clinical trials and emphasized PPB’s dedication to advancing healthcare through safe and ethical research. […]